Contact
Please use this form to send email to PR contact of this press release:
Galera Therapeutics Raises $150 Million for GC4419 Phase 3 Trial and Pre-Commercialization Activities in Lead Indication
TO:
Please use this form to send email to PR contact of this press release:
Galera Therapeutics Raises $150 Million for GC4419 Phase 3 Trial and Pre-Commercialization Activities in Lead Indication
TO: